Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options

• 主要な著者: Amirah Azzeri (著者), Maznah Dahlui (著者), Rosmawati Mohamed (著者), Scott Alexander McDonald (著者), Hafiz Jaafar (著者), Fatiha Hana Shabaruddin (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

IntroductionA scaled-up treatment cascade with direct-acting antiviral (DAA) therapy is necessary to achieve global WHO targets for hepatitis C virus (HCV) elimination in Malaysia. Recently, limited access to sofosbuvir/daclatasvir (SOF/DAC) is available through compulsory licensing, with access to...